DCPH – deciphera pharmaceuticals, inc. (US:NASDAQ)

News

Lifshitz Law PLLC Announces Investigations of DCPH, SLCA, HCP, and HTLF
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MCBC, DCPH, HTLF, TBNK
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More [Yahoo! Finance]
DECIPHERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Deciphera Pharmaceuticals, Inc. - DCPH
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) was downgraded by analysts at Leerink Partnrs from an "outperform" rating to a "market perform" rating.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com